Effects of mazindol in two patients with Prader-Willi syndrome

This publication has 8 references indexed in Scilit:

• Charting of Daily Weight Pattern Reinforces Maintenance of Weight Reduction in Moderately Obese Patients
  The Lancet Healthy Longevity, 1992
• Low affinity hypothalamic [3H]mazindol binding: a probe for hypothalamic body weight regulation?
  Appetite, 1989
• Development of a Young Man with Prader-Willi Syndrome and Secondary Functional Encopresis
  The Canadian Journal of Psychiatry, 1989
• Regulation of [3H]mazindol binding to subhypothalamic areas: Involvement in glucoprivic feeding
  Brain Research Bulletin, 1986
• Dopaminergic and serotoninergic anorectics differentially antagonize insulin- and 2-DG-induced hyperphagia
  Life Sciences, 1985
• Suppression of prolactin and growth hormone responses to 2-deoxy-D-glucose-induced glucoprivation by mazindol in humans
  Metabolism, 1981
• Clinical Evaluation of the Anorexic Activity and Safety of 42-548 in Children
  Clinical Pediatrics, 1973
• Prader-Willi syndrome: A resumé of 32 cases including an instance of affected first cousins,one of whom is of normal stature and intelligence
  The Journal of Pediatrics, 1972